Research Group on Respiratory Diseases
Metabolism and Organic Damage Area
Study of respiratory complications in patients with neuromuscular diseases. Utility of mechanical ventilation and other respiratory supports
Implication of early diagnosis of obstructive airway diseases in the prognosis and follow-up of patients. Emphysema early detection program. Program for early detection of Alpha 1 Antitrypsin Deficiency
Early follow-up program for COPD with exacerbator phenotype
Severe Asthma control program
Control of respiratory disorders during sleep as prevention of cardiovascular risk factors
Early diagnosis of idiopathic interstitial respiratory diseases (IPF) and secondary diseases (drug toxicity and post-BMT)
Coordinator
RESEARCHERS
Established, R3
Jesús Sancho ChinestaJosé Franco SerranoMª Cruz González VillaescusaMª Luisa Briones Urtiaga
Recognised/Emerging, R2
Carmen Muñoz EstebanFrancisco Carrión ValeroJosé Luis Díaz CordobésPilar Bañuls Polo
First Stage, R1
Alba Mulet ArabiNieves Navarro SorianoPaola Lisseth Ordóñez GómezSantos Ferrer Espinosa
STAFF
Collaborating Researchers
Ana Ferrer PonsAna María Ferrer MartíAndrés Vales VeigaAntonio Herrera CuadrosCarlos Alonso RuzoElia Giménez SamblasEnric Burés SalesErick Monclou GarzónHeidi Mora BastidaIrene Tur CrucesJulia Tarrasó CastilloMariam García AlfaroMiriam Bernaola GarridoNatividad Blasco AnguloPablo Royo SimóRamón Cercos GonzálezYolanda García San Juan
Nurse
Technicians
Administrative assistant
Publications
Clinical Practice Guideline of Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on Pharmacological Treatment of Tobacco Dependence 2023. Rabade-Castedo C, de Granda-Orive J, Riesco-Miranda J, De Higes-Martinez E, Ramos-Pinedo A, Cabrera-Cesar E, Signes-Costa Minana J, Garcia Rueda M, Pastor-Espla E, Jimenez-Ruiz C. Archivos de Bronconeumologia. 2023 Oct;59(10):651-661. doi: 10.1016/j.arbres.2023.07.024. PMID: 37567792
Clinical profile and determinants of mortality in patients with interstitial lung disease admitted for COVID-19. Mulet A, Nunez-Gil I, Carbonell J, Soriano J, Viana-Llamas M, Raposeiras-Roubin S, Romero R, Alfonso-Rodriguez E, Uribarri A, Feltes G, Becerra-Munoz V, Santoro F, Pepe M, Castro-Mejia A, Chipayo D, Corbi-Pascual M, Lopez-Pais J, Vedia O, Manzone E, Molina-Romera G, Espejo-Paeres C, Lopez-Masjuan A, Velicki L, Fernandez-Ortiz A, El-Battrawy I, Signes-Costa J, On Behalf Of Hope Team. Journal of Clinical Medicine. 2023 Jun 2;12(11):3821. doi: 10.3390/jcm12113821. PMID: 37298018
Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry. Miravitlles M, Turner AM, Torres-Duran M, Tanash H, Rodriguez-Garcia C, Lopez-Campos JL, Chlumsky J, Guimaraes C, Rodriguez-Hermosa JL, Corsico A, Martinez-Gonzalez C, Hernandez-Perez JM, Bustamante A, Parr DG, Casas-Maldonado F, Hecimovic A, Janssens W, Lara B, Barrecheguren M, Gonzalez C, Stolk J, Esquinas C, Clarenbach CF. Respiratory Research. 2023 Feb 18;24(1):57. doi: 10.1186/s12931-023-02340-6. PMID: 36800958
Effect of serum from patients with ST-segment elevation myocardial infarction on endothelial cells. Rios-Navarro C, Gavara J, Dios E, Perez-Sole N, Molina-Garcia T, Marcos-Garces V, Ruiz-Sauri A, Bayes-Genis A, Carrion-Valero F, Chorro F, Bodi V. Revista Espanola de Cardiologia (English ed.). 2023 Sep 9;S1885-5857(23)00238-4. doi: 10.1016/j.rec.2023.08.004. PMID: 37696331
Autoantibodies against type I IFNs in patients with critical influenza pneumonia. Zhang Q, Pizzorno A, Miorin L, Bastard P, Gervais A, Le Voyer T, Bizien L, Manry J, Rosain J, Philippot Q, Goavec K, Padey B, Cupic A, Laurent E, Saker K, Vanker M, Sarekannu K, Garcia-Salum T, Ferres M, Le Corre N, Sanchez-Cespedes J, Balsera-Manzanero M, Carratala J, Retamar-Gentil P, Abelenda-Alonso G, Valiente A, Tiberghien P, Zins M, Debette S, Meyts I, Haerynck F, Castagnoli R, Notarangelo LD, Gonzalez-Granado LI, Dominguez-Pinilla N, Andreakos E, Triantafyllia V, Rodriguez-Gallego C, Sole-Violan J, Ruiz-Hernandez JJ, Rodriguez de Castro F, Ferreres J, Briones M, Wauters J, Vanderbeke L, Feys S, Kuo CY, Lei WT, Ku CL, Tal G, Etzioni A, Hanna S, Fournet T, Casalegno JS, Queromes G, Argaud L, Javouhey E, Rosa-Calatrava M, Cordero E, Aydillo T, Medina RA, Kisand K, Puel A, Jouanguy E, Abel L, Cobat A, Trouillet-Assant S, Garcia-Sastre A, Casanova JL. Journal of Experimental Medicine. 2022 Nov 7;219(11):e20220514. doi: 10.1084/jem.20220514. PMID: 36112363
Chronic oral anticoagulation therapy and prognosis of patients admitted to hospital for COVID-19: insights from the HOPE COVID-19 Registry. Rivera-Caravaca J, Nunez-Gil I, Lip G, Uribarri A, Viana-Llamas M, Gonzalez A, Castro-Mejia A, Gonzalez B, Alfonso E, Prieto J, Cavallino C, Cortese B, Feltes G, Fernandez-Rozas I, Signes-Costa J, Huang J, Aguado M, Pepe M, Romero R, Cerrato E, Becerra-Munoz V, Roubin S, Santoro F, Bagur R, Sposato L, El-Battrawy I, Masjuan A, Fernandez-Ortiz A, Estrada V, Macaya C, Marin F. International Journal of Clinical Practice. 2022 May 26;2022:7325060. doi: 10.1155/2022/7325060. PMID: 35685504
Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study). Garcia de Guadiana-Romualdo L, Rodriguez Rojas C, Morell-Garcia D, Andaluz-Ojeda D, Rodriguez Mulero M, Rodriguez-Borja E, Ballesteros-Vizoso A, Calvo M, Albert-Botella L, Pozo Giraldez A, Llompart-Alabern I, Bolado Jimenez C, Hernandez Olivo M, Fernandez Presa L, Ortega-Perez J, Fora Romero M, Campos-Rodriguez V, Ballester Ferriz A, Guiu-Marti A, Pinilla Arribas L, Galindo Martinez M, Puerto-Lara E, Lopez Tarazaga A, Ros Braquehais M, Nogales Martin L, Juez Santamaria C, Trapiello Fernandez W, Espinilla Fernandez V, Havelka A, Albaladejo-Oton M. Inflammation research. 2022 Jan;71(1):57-67. doi: 10.1007/s00011-021-01516-4. PMID: 34718856
Clinical and economic impact of long-term inhaled corticosteroid withdrawal in patients with chronic obstructive pulmonary disease treated with Triple Therapy in Spain. Garcia V, Vallejo-Aparicio L, Ismaila A, Sicras-Mainar A, Sicras-Navarro A, Gonzalez C, Cuervo R, Shukla S, Garcia-Penuela M. International Journal of Chronic Obstructive Pulmonary Disease. 2022 Sep 7;17:2161-2174. doi: 10.2147/COPD.S367708. PMID: 36101793
Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths. Bastard P, Gervais A, Le Voyer T,et al. Science Immunology. 2021 Aug 19;6(62):eabl4340. doi: 10.1126/sciimmunol.abl4340. PMID: 34413139
Clinical profile and predictors of in-hospital mortality among older patients admitted for COVID-19. Becerra-Munoz V, Nunez-Gil I, Eid C, Aguado M, Romero R, Huang J, Mulet Arabi A, Ugo F, Rametta F, Liebetrau C, Aparisi A, Fernandez-Rozas I, Viana-Llamas M, Feltes G, Pepe M, Moreno-Rondon L, Cerrato E, Raposeiras-Roubin S, Alfonso E, Carrero-Fernandez A, Buzon-Martin L, Abumayyaleh M, Gonzalez A, Ortiz A, Macaya C, Estrada V, Fernandez-Perez C, Gomez-Doblas J. Age and Ageing. 2021 Feb 26;50(2):326-334. doi: 10.1093/ageing/afaa258. PMID: 33201181
COVID-19 and the impact of arterial hypertension-An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany). El-Battrawy I, Nunez-Gil I, Abumayyaleh M, Estrada V, Becerra-Munoz V, Uribarri A, Fernandez-Rozas I, Feltes G, Arroyo-Espliguero R, Trabattoni D, Lopez-Pais J, Pepe M, Romero R, Castro-Mejia A, Cerrato E, Astrua T, D’Ascenzo F, Fabregat-Andres O, Signes-Costa J, Marin F, Buonsenso D, Bardaji A, Tellez M, Fernandez-Ortiz A, Macaya C, Akin I. European Journal of Clinical Investigation. 2021 Aug 19;e13582. doi: 10.1111/eci.13582. PMID: 34409593
COVID-19 and Tobacco. Rabade Castedo C, Signes-Costa J, Jimenez-Ruiz C. Archivos de Bronconeumologia. 2021 Jan;57 Suppl 1:5-6. doi: 10.1016/j.arbres.2020.07.014. PMID: 32917432
Projects
Title: El papel del estrés oxidativo y la vía NRF2 en determinar resistencia a quimioinmunoterapia de primera línea en pacientes con cáncer de pulmón no microcitico avanzado KRAS mutado
Funding body: Instituto de Salud Carlos III – Cofinanciado FEDER
Principal Investigator: Valentina Gambardella
Duration: 2023 – 2025
Total budget: 111.320 €
Title: Terapia celular combinada para pacientes COVID-19 de alto riesgo de mortalidad (DECODE-19)
Funding body: Instituto de Salud Carlos III – Cofinanciado FEDER
Principal Investigator: Bernat Soria Escoms
Duration: 2021 – 2024
Total budget: 459.800 €
Title: Efecto de la infección por COVID-19 sobre la longitud del telómero y parámetros de función mitocondrial y su relación con la evolución a fibrosis pulmonar de tipo idiopático
Funding body: Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital
Principal Investigator: Federico Vicente Pallardó Calatayud
Duration: 2021 – 2022
Total budget: 62.280 €
Title: Cambios en los test de función pulmonar en pacientes con neumonia por CoVid19
Funding body: Instituto de Salud Carlos III – Cofinanciado FEDER
Principal Investigator: Jaime Signes-Costa
Duration: 2020 – 2021
Total budget: 73.500 €
Title: Estudios genómicos de susceptibilidad y gravedad en infección neumocócica en niños y adultos
Funding body: Instituto de Salud Carlos III – Cofinanciado FEDER
Principal Investigator: Carlos Rodríguez Gallego
Duration: 2017 – 2019
Total budget:
+ Info
252nd ENMC international workshop: Developing best practice guidelines for management of mouthpiece ventilation in neuromuscular disorders. March 6th to 8th 2020, Amsterdam, the Netherlands. Chatwin M, Gonçalves M, Gonzalez-Bermejo J, Toussaint M, ENMC Respiratory Therapy Consortium. Neuromuscular disorders. 2020 Sep;30(9):772-781. doi: 10.1016/j.nmd.2020.07.008. PMID: 32859499
Doctoral candidate: Ribera I Osca, Joan Antoni
Director(s): Martín Moreno, José María; Carrión Valero, Francisco
Date of the defense: 17/02/2020
University: Universitat de València